Focal Therapeutics has developed the BioZorb tissue marker, an implantable device that surgeons use to mark the site of tissue removal in three dimensions. This marker is applicable to various forms of radiation therapy and aids in treatment planning, patient positioning, and long-term follow-up. The company's leadership team has extensive experience in the development and commercialization of medical devices, particularly in the field of breast cancer care. Initially, BioZorb is being offered to surgeons and radiation oncologists who treat breast cancer patients.